Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.

Enfusion, Inc.

Allvue provides alternative investment software and investment support for private capital managers, focusing on streamlining fund operations throughout the fund lifecycle.

Allvue

Enfusion simplifies investment management operations by uniting front, middle and back-office functions under a single cloud-native SaaS platform built on a shared golden data set.

Metric
Company Name	Enfusion, Inc.	Allvue
Symbol	ENFN
MSH ID	COM:ENFUSION	COM:ALLVUESYSTEMS
Market	STOCKS	PRIVATE
Sector	Technology	Financial Services & Finance
Industry	Software - Application	Financial Technology
Country	US	US
Stage
Employee Count	1.10K
Website	enfusion.com	allvuesystems.com
LinkedIn
Founders

Metric
Market Cap	769.30M
Enterprise Value
Monthly Web Traffic		19.72K
Web Traffic Growth		-0.58
Valuation
Raised Capital

Metric
Revenue	174.53M
Revenue (LTM)
Revenue (NTM)
Gross Profit	116.89M
EBITDA	20.54M
Operating Income	11.95M
Net Income	6.03M
EPS	0.07
Diluted EPS	0.07
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.67
Operating Profit Margin	0.07
EBITDA Margin	0.12
Net Profit Margin	0.04
Return on Equity	0.14
Return on Assets	0.07
Return on Capital Employed	0.13

COM:ENFUSION

Enfusion

Last Close

10.10

22/11 21:00

Market Cap

769.30M

Beta: -

Volume Today

390.78K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	86.20
P/B Ratio	13.49
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.06
EV Multiple	58.11

Metric
Days Sales Outstanding	53.82
Days Payables Outstanding	8.85
Days Inventory Outstanding
Operating Cycle	65.25
Cash Conversion Cycle	60.47
Asset Turnover	1.64

Metric
Operating Cash Flow	24.48M
Free Cash Flow	14.81M
Cash Flow to Debt	1.62
Operating Cash Flow/Sales	0.14
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	35.60M
Accounts Receivable	-3.68M
Inventory
Goodwill
Debt to Capitalization	0.22
Debt to Assets	0.16
Current Ratio	3.79
Quick Ratio	4.15

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.05
R&D to Revenue	0.11
SG&A to Revenue	0.37